us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $94.30

    as of November 06, 2025
  • YTD RETURNS
    11.15%

    as of November 06, 2025
  • Total Net Assets
    $1.07B

    as of November 06, 2025
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
  • Industry Leaders: Index methodology favors the largest companies in the industry
  • Global Scope: Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 2.84 11.99 9.06 3.68 10.50 11.52 5.63 9.24
PPH (Share Price) 2.84 12.06 9.13 3.61 10.52 11.54 5.62 9.32
MVPPHTR (Index) 2.85 11.99 8.73 3.23 10.02 11.12 5.41 9.05
Performance Differential (NAV - Index) -0.01 -- 0.33 0.45 0.48 0.40 0.22 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.63 3.39 6.05 -2.88 12.60 9.85 5.68 9.08
PPH (Share Price) 1.67 3.44 6.11 -2.77 12.61 9.82 5.68 9.16
MVPPHTR (Index) 1.65 3.37 5.71 -3.33 12.10 9.46 5.45 8.89
Performance Differential (NAV - Index) -0.02 0.02 0.34 0.45 0.50 0.39 0.23 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 11/06/2025

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $94.30
$94.30 		820,199
578,024 		$0.64 / +0.68%
$0.62 / +0.66% 		+11.15%
+11.20% 		$0.00
0.00% 		0.03%

Fees

Holdings

Daily Holdings (%) as of 11/05/2025

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 23.24
BBG000BNBDC2
267,710
 Stock 247,848,595 --
NVS US
 Novartis Ag 9.15
BBG000LYF3S8
777,978
 Stock 97,636,239 --
MRK US
 Merck & Co Inc 7.19
BBG000BPD168
908,776
 Stock 76,691,607 --
NVO US
 Novo Nordisk A/S 6.49
BBG000BQBKR3
1,429,063
 Stock 69,252,393 --
MCK US
 Mckesson Corp 5.10
BBG000DYGNW7
64,391
 Stock 54,362,746 --
GSK US
 Gsk Plc 4.91
BBG000BLB481
1,122,278
 Stock 52,399,160 --
PFE US
 Pfizer Inc 4.74
BBG000BR2B91
2,055,533
 Stock 50,586,667 --
JNJ US
 Johnson & Johnson 4.51
BBG000BMHYD1
258,560
 Stock 48,092,160 --
SNY US
 Sanofi Sa/France 4.43
BBG000BBD5N1
963,850
 Stock 47,228,650 --
ABBV US
 Abbvie Inc 4.37
BBG0025Y4RY4
214,777
 Stock 46,557,210 --
AZN US
 Astrazeneca Plc 4.28
BBG000BZ0DK8
562,476
 Stock 45,644,927 --
BMY US
 Bristol-Myers Squibb Co 4.20
BBG000DQLV23
964,070
 Stock 44,800,333 --
COR US
 Cencora Inc 4.02
BBG000MDCQC2
121,016
 Stock 42,839,664 --
ZTS US
 Zoetis Inc 3.44
BBG0039320N9
304,163
 Stock 36,648,600 --
HLN US
 Haleon Plc 2.90
BBG018GZNCH6
3,323,563
 Stock 30,942,372 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.33
BBG000LF8708
1,825,749
 Stock 24,811,929 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.08
BBG000C0CD58
899,913
 Stock 22,137,860 --
VTRS US
 Viatris Inc 0.61
BBG00Y4RQNH4
609,908
 Stock 6,556,511 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.53
BBG000G9CGL0
41,471
 Stock 5,690,651 --
ELAN US
 Elanco Animal Health Inc 0.45
BBG00LJYS1P8
222,177
 Stock 4,799,023 --
CORT US
 Corcept Therapeutics Inc 0.37
BBG000BKJG33
51,540
 Stock 3,950,541 --
AXSM US
 Axsome Therapeutics Inc 0.34
BBG00B6G7GL7
26,934
 Stock 3,654,674 --
BHC US
 Bausch Health Cos Inc 0.13
BBG000DLFM21
209,283
 Stock 1,418,939 --
OGN US
 Organon & Co 0.10
BBG00ZQRGW24
166,735
 Stock 1,063,769 --
PRGO US
 Perrigo Co Plc 0.10
BBG000CNFQW6
68,514
 Stock 1,034,561 --
-USD CASH-
 -0.00
--
-1,004
 Cash Bal -1,004 --
--
Other/Cash -0.01
--
0
 Cash -75,288 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 10/31/2025

  • Sector

    % of Net Assets

  • Health Care

    100.00

  • Other/Cash

    -0.00

Country Weightings (%) as at 10/31/2025

  • Country

    % of Net Assets

  • United States

    63.13

  • United Kingdom

    12.31

  • Switzerland

    9.14

  • Denmark

    6.71

  • France

    4.63

  • Japan

    2.33

  • Israel

    1.75

  • Other/Cash

    -0.00

Distributions

Yields  as of  11/06/2025

Distribution Frequency

Quarterly

30-Day SEC Yield

2.01%

Distribution Yield

1.67%

12 Month Yield

2.05%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 2.01% on 11/06/25. Distributions may vary from time to time.

Team

Literature

PPH